End-of-day quote
Shanghai S.E.
23:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
4.72
CNY
|
-0.42%
|
|
+0.21%
|
-4.45%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,420
|
2,775
|
2,480
|
3,388
|
4,657
|
4,383
|
Enterprise Value (EV)
1 |
4,238
|
3,712
|
3,015
|
4,360
|
5,804
|
4,769
|
P/E ratio
|
-5.74
x
|
30.6
x
|
47.4
x
|
62.1
x
|
27
x
|
19
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.69
x
|
0.81
x
|
0.8
x
|
1
x
|
1.09
x
|
1.01
x
|
EV / Revenue
|
1.2
x
|
1.09
x
|
0.97
x
|
1.29
x
|
1.35
x
|
1.1
x
|
EV / EBITDA
|
-26.7
x
|
14
x
|
18.4
x
|
93.5
x
|
11.7
x
|
8.37
x
|
EV / FCF
|
-19.8
x
|
5.33
x
|
-8.07
x
|
65.6
x
|
75.1
x
|
9.29
x
|
FCF Yield
|
-5.05%
|
18.8%
|
-12.4%
|
1.52%
|
1.33%
|
10.8%
|
Price to Book
|
1.26
x
|
1.38
x
|
1.22
x
|
1.62
x
|
1.22
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
547,405
|
547,405
|
547,405
|
547,405
|
863,943
|
887,153
|
Reference price
2 |
4.420
|
5.070
|
4.530
|
6.190
|
5.390
|
4.940
|
Announcement Date
|
18/04/19
|
08/04/20
|
07/04/21
|
31/03/22
|
17/04/23
|
15/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,521
|
3,416
|
3,111
|
3,384
|
4,284
|
4,353
|
EBITDA
1 |
-158.5
|
266
|
163.6
|
46.62
|
496.5
|
569.8
|
EBIT
1 |
-275.3
|
145.6
|
70.39
|
-8.792
|
274.5
|
344.1
|
Operating Margin
|
-7.82%
|
4.26%
|
2.26%
|
-0.26%
|
6.41%
|
7.9%
|
Earnings before Tax (EBT)
1 |
-410.5
|
97.85
|
73.72
|
65.27
|
203.1
|
307.7
|
Net income
1 |
-421.7
|
90.65
|
52.32
|
54.55
|
152.6
|
228.6
|
Net margin
|
-11.98%
|
2.65%
|
1.68%
|
1.61%
|
3.56%
|
5.25%
|
EPS
2 |
-0.7703
|
0.1656
|
0.0956
|
0.0996
|
0.2000
|
0.2600
|
Free Cash Flow
1 |
-214
|
697
|
-373.8
|
66.41
|
77.27
|
513.3
|
FCF margin
|
-6.08%
|
20.4%
|
-12.01%
|
1.96%
|
1.8%
|
11.79%
|
FCF Conversion (EBITDA)
|
-
|
261.99%
|
-
|
142.46%
|
15.56%
|
90.08%
|
FCF Conversion (Net income)
|
-
|
768.88%
|
-
|
121.75%
|
50.63%
|
224.58%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/04/19
|
08/04/20
|
07/04/21
|
31/03/22
|
17/04/23
|
15/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,819
|
936
|
536
|
971
|
1,147
|
387
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-11.48
x
|
3.52
x
|
3.274
x
|
20.83
x
|
2.311
x
|
0.6788
x
|
Free Cash Flow
1 |
-214
|
697
|
-374
|
66.4
|
77.3
|
513
|
ROE (net income / shareholders' equity)
|
-19.6%
|
4.46%
|
2.37%
|
2.33%
|
4.53%
|
5.89%
|
ROA (Net income/ Total Assets)
|
-2.1%
|
1.19%
|
0.63%
|
-0.08%
|
1.77%
|
2.12%
|
Assets
1 |
20,127
|
7,588
|
8,259
|
-67,677
|
8,638
|
10,766
|
Book Value Per Share
2 |
3.510
|
3.670
|
3.730
|
3.830
|
4.410
|
4.640
|
Cash Flow per Share
2 |
1.900
|
1.820
|
1.960
|
1.470
|
1.780
|
2.010
|
Capex
1 |
303
|
77.7
|
235
|
194
|
197
|
111
|
Capex / Sales
|
8.59%
|
2.27%
|
7.57%
|
5.73%
|
4.61%
|
2.55%
|
Announcement Date
|
18/04/19
|
08/04/20
|
07/04/21
|
31/03/22
|
17/04/23
|
15/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.45% | 582M | | +14.90% | 9.03B | | +45.55% | 2.37B | | -11.82% | 1.05B | | +22.34% | 860M | | -7.53% | 760M | | +20.75% | 692M | | +16.71% | 651M | | +14.03% | 621M | | -14.98% | 617M |
Purification & Treatment Equipment
|